Publisher： Karger
E-ISSN： 2296-5262|23|2|40-45
ISSN： 2296-5270
Source： Oncology Research and Treatment, Vol.23, Iss.2, 2000-05, pp. : 40-45
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Optimierung der primären Chemotherapie des fortgeschrittenen Ovarialkarzinoms
Oncology Research and Treatment, Vol. 23, Iss. 2, 2000-05 ,pp. :
Access to resources
Recommend
Standards in der Therapie des Ovarialkarzinoms
Der Pathologe, Vol. 28, Iss. 3, 2007-05 ,pp. :
Neue Chemotherapeutika in der Therapie des fortgeschrittenen Magenkarzinoms
Oncology Research and Treatment, Vol. 26, Iss. 7, 2004-11 ,pp. :
Anthrazykline in der Therapie des Ovarialkarzinoms – Vergangenheit, Gegenwart und Zukunft
Oncology Research and Treatment, Vol. 23, Iss. 2, 2000-05 ,pp. :
Erfahrungen mit Caelyx® in der Therapie des metastasierten Mammakarzinoms
Oncology Research and Treatment, Vol. 23, Iss. 2, 2000-05 ,pp. :